AMP-Deoxynojirimycin is primarily used in biochemical research to study glycosidase enzymes. It acts as an inhibitor, helping researchers understand the mechanisms of these enzymes in various biological processes. This compound is particularly valuable in investigating metabolic pathways involving carbohydrate processing, which can provide insights into diseases like diabetes and lysosomal storage disorders. Additionally, it is utilized in the development of potential therapeutic agents targeting glycosidase-related conditions. Its application extends to the study of viral infections, as glycosidases play a role in viral replication, making it a tool for exploring antiviral strategies.